Do you routinely obtain next generation sequencing for patients with metastatic renal cell carcinoma and if so, what is your approach to incorporating these results into treatment decision making?

Topics: Genitourinary Cancers • Medical Oncology • Renal Cell Carcinoma • NCI-CCC Tumor Board Question • Duke • NCI-CCC GU Tumor Board Question

Answer from: Medical Oncologist at Academic Institution

Currently, I do not routinely send NGS for patients with metastatic clear cell RCC as we do not have level 1 evidence that these results should guide treatment decisions. We do not have "actionable mutations" that would change or guide our treatment of choice. IMDC still remains our best risk strati...

Comments

Medical Oncologist
Thank you @Matthew K. Labriola for mentioning the ...

Related Questions